𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients

✍ Scribed by A.T. Vila; L. Puig; M.T. Fernández-Figueras; A.M. Laiz; D. Vidal; A. Alomar

Book ID
108668203
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
375 KB
Volume
153
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy and safety of leflunomide i
The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: A five-year followup study
✍ J. R. Kalden; M. Schattenkirchner; H. Sörensen; P. Emery; C. Deighton; B. Rozman 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

## Abstract ## Objective To investigate the efficacy and safety of leflunomide beyond 2 years in a multinational, open‐label extension of 2 phase III double‐blind studies. ## Methods Patients with rheumatoid arthritis (RA) who received leflunomide (100 mg/day for 3 days, 10 mg/day or 20 mg/day t

Combination therapy with etanercept and
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate
✍ Mark C. Genovese; Stanley Cohen; Larry Moreland; Deborah Lium; Sean Robbins; Ric 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## Objective To determine the potential for additive or synergistic effects of combination therapy with the selective anti–tumor necrosis factor α agent etanercept and the anti–interleukin‐1 agent anakinra. ## Methods Two hundred forty‐four patients in whom rheumatoid arthritis (RA)